On September 6, Zhang Xiang, President of The University of Hong Kong, led a delegation to visit Chia Tai Tianqing, a core enterprise of Sino Biopharm (1177.HK). The delegation included Vice President Lin Chen of The University of Hong Kong and renowned entrepreneurs such as Wang Jianguo, Chairman of Five Star Holdings; Fan Min, Co-founder of Ctrip.com; Wang Zhihan, Chairman of the Board of Goheal Group; and Yang Xiao, Chairman of Renhe Pharmacy Co., Ltd. The Chief Executive Officer of Sino Biopharm and Chairman of Chia Tai Tianqing received the visiting delegation. The parties engaged in a dialogue on topics such as innovative breakthroughs, clinical translation, and cross-industry integration, building consensus for multi-domain collaborative innovation.

Mr. Eric Tse recalled the fruitful exchange during The University of Hong Kong's first visit in April this year and expressed his anticipation for the participation of entrepreneurs from various industries this time. Mr. Eric Tse pointed out that the HKU Li Ka Shing Faculty of Medicine has strong R&D capabilities in the fields of oncology and hepatology, especially the professional platform built by the "Greater Bay Area International Clinical Trial Institute", which makes it a natural "partner" for the company's industrialization capabilities, honed over many years in the pharmaceutical industry. Last month, two of the company's self-developed products served local patients through Hong Kong's "Named Patient Program (NPP)". In the future, it will fully leverage Hong Kong's role as a "super-connector" to break down regional barriers and accelerate the translation of scientific research into clinical applications. At the same time, the company is also actively exploring the promotion of the establishment of an Asia-Pacific multicenter clinical trial alliance to help the leapfrog advancement of China's biopharmaceutical industry.

Mr. Zhang Xiang affirmed Sino Biopharm's robust resilience in maintaining dual growth in revenue and net profit amidst the profound changes in the pharmaceutical market landscape. He introduced that The University of Hong Kong ranks 11th globally and among the top in Asia this year. The newly established School of Biomedical Engineering will further break down the disciplinary barriers between pharmacy and engineering, providing more comprehensive academic support for industrial innovation. Regarding the industry-academia-research cooperation model, Zhang Xiang proposed a more flexible approach: leveraging Hong Kong's international and liberal academic atmosphere to build an international open cooperation platform, bringing in top global scientists to jointly tackle "globally new" technology fields, and achieving source innovation breakthroughs that meet both academic research and industrial needs.

During the exchange session, all parties present expressed confidence in cross-industry cooperation and communication. Mr. Eric Tse stated that the successful marketing experience of Kidswant, under Five Star Holdings, offers significant reference value. Beijing Tide Pharmaceutical, a member company of Sino Biopharm and a leading enterprise in transdermal patches, has developed products like the Rivastigmine Transdermal Patch (Suleda®) and Tulobuterol Patch (Deruituo®). While expanding in the hospital market, there is still huge potential to be tapped in the retail channel, and he looks forward to commercial cooperation through the integration of both parties' channel resources. In addition, the discussion also covered topics such as the development and innovation of traditional Chinese medicine and the collaborative development of the Southeast Asian market.

During the visit, the delegation toured the Chia Tai Tianqing Digital Intelligence Future Experience Center, the R&D institute, and the biologics workshop, gaining a close-up understanding of the company's core technological strengths. Chia Tai Tianqing Vice Presidents Chen Hui, Zhao Wei, Gao Fan, and Yang Ling, along with core business team members from R&D, marketing, production, BD, and HR, accompanied the visit.

Declaration:

The copyright of this article is owned by the original author or our company. Unauthorized use by means of reprinting, copying, filming, adapting, or compiling is prohibited. The portrait rights of the individuals appearing in this article belong to the individuals themselves. Unauthorized use is prohibited.